Reactions Weekly

November 2019, Volume 1780, Issue 1, pp 3–3 | Cite as

US FDA enhancing postmarketing drug safety surveillance

News item

First Online: 23 November 2019

• 114 Downloads

This is a preview of subscription content, log in to check access.

Reference

1. FDA. Statement on the agency's efforts to protect patients through postmarket drug safety surveillance practices. Internet Document : 6 Nov 2019. Available from: URL: https://www.fda.gov/news-events/press-announcements/statement-agencys-efforts-protect-patients-through-postmarket-drug-safety-surveillance-practices

Copyright information

© Springer International Publishing AG 2019